Evidence map›Paper›PMID 42219707›Full record

ArticleThe Journal of organic chemistry2026

Synthesis of Peptide-Oligonucleotide Conjugates via Condensation of a Lysine Side-Chain with a Thioester.

So Muramoto, Takashi Osawa, Satoshi Obika

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

So MuramotoGraduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.
Takashi OsawaGraduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.ORCID 0009-0004-5304-3861
Satoshi ObikaGraduate School of Pharmaceutical Sciences, The University of Osaka, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.ORCID 0000-0002-6842-6812

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide-oligonucleotide conjugates (POCs) are promising drug delivery tools for oligonucleotide therapeutics. They are conventionally prepared by separately synthesizing peptides and oligonucleotides, introducing reactive functional groups into both molecules, and forming conjugates via click chemistry or maleimide-thiol coupling. However, these approaches generally require prefunctionalization of peptides or rely on the presence of cysteine residues, limiting their applicability to native peptides. Consequently, conjugation of peptides lacking thiol groups on cysteine residues to oligonucleotides remains challenging. Therefore, we aimed to develop a new conjugation method for POCs that does not require chemical modification of native peptides. To achieve this objective, we devised a method to prepare POCs via condensation between the ε-amino group of a lysine side-chain and a thioester-modified oligodeoxynucleotide. In establishing our POC synthesis method, the addition of 2-sulfanylmethyl-4-dimethylaminopyridine, which increases thioester reactivity, enabled rapid and efficient conjugation under mild conditions. Under the optimized conditions, conjugation proceeded efficiently with amino acids and simple trimer peptides having unprotected α-amino groups. Furthermore, conjugation with functional peptides demonstrated that this method is applicable to the synthesis of both linear and cyclic peptide-oligodeoxynucleotide conjugates.

Indexed as

EstersLysineOligonucleotidesPeptidesSulfhydryl CompoundsMolecular StructureEstersLysineOligonucleotidesPeptidesSulfhydryl Compounds

Identifiers

PMID42219707
PMCPMC13270635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.